Home > Information > What's New 2017
What's New 2017
- Dec. 22, 2017
- T. Matsuda takes office of International Association of Cancer Registries President
- Dec. 18, 2017
- Cancer Statistics in Japan; Table download
- Dec. 14, 2017
- National Cancer Center - IARC Seminar 2
- Dec. 5, 2017
- NCC signs comprehensive MoU with WHO/IARC
- Nov. 27, 2017
- Asian Early Phase Oncology Drug Development Consortium Formed
- Nov. 21, 2017
- New Agreement with National Cancer Center, Indonesia
- Nov. 14, 2017
- Lithuanian Health Minister Visit
- Oct. 30, 2017
- Cancer Statistics in Japan; Table download
- Oct. 27, 2017
- Collaborative Research on Fully-personalized Cancer Neoantigen Vaccine
- Oct. 27, 2017
- Projected Cancer Statistics, 2017
- Oct. 26, 2017
- National Cancer Center - IARC Seminar 1
- Oct. 16, 2017
- Commencement of Collaborative Research on Measurement of Exosomes in Blood from Cancer Patients
- Aug. 3, 2017
- Japan-Singapore lead international research in discovering potential targeted treatments for biliary tract cancer
- Aug. 1, 2017
- On-Table Adaptive Radiation Therapy
- Jul. 31, 2017
- The MASTER KEY PROJECT
Genomic medicine in Rare Cancers:
A collaboration between the industry and academia - Jul. 21, 2017
- Cancer Registration Seminar in Myanmar
- Jul. 11, 2017
- Cancer Statistics in Japan; Table download（Link to Cancer Information Service）
- Jun. 26, 2017
- A novel biomarker for development of a new screening technique for early-stage pancreatic cancer and precancerous conditions associated with risk of pancreatic malignancy - experimental screening in Kagoshima Prefecture
- Jun. 16, 2017
- National Cancer Center hosts Iranian Delegation
- May 30, 2017
- WHO/International Agency for Research on Cancer establishes National Cancer Center as Global Initiative for Cancer Registry Development Collaborating Centre
- Apr. 27, 2017
- Elucidation of the mechanism of MLL-rearranged leukemia Use of two molecularly targeted drugs as novel therapy
- Mar. 1, 2017
- Commencement of Phase 1 Trial for the Mutant IDH1 Inhibitor (DS-1001)Targeting Malignant Brain Tumors
- Feb. 28, 2017
- Malignant extracellular vesicles derived from ovarian cancer cells facilitate peritoneal dissemination, and the vesicles can be promising targets for improving patient outcomes.
- Feb. 21, 2017
- Signing MOU with the National Cancer Research Institute (UK)